Psilocybin

Psilocybe Mushrooms statues

Albert Hofmann Oct 1993

Error creating thumbnail:

Golden teacher kookoskuidussa 3

Timothy-Leary-Los-Angeles-1989

Prefrontal cortex

Error creating thumbnail:

Drug danger and dependence-no title

Psilocybin is a naturally occurring psychedelic compound produced by more than 200 species of fungi, commonly known as "magic mushrooms." Psilocybin is converted to psilocin in the human body, which is the chemical responsible for the psychedelic effects. These effects include altered perception of time and space, vivid visual and auditory hallucinations, and profound changes in thought, mood, and self-awareness. The use of psilocybin and psilocybin-containing mushrooms dates back thousands of years, with evidence of use in religious and spiritual rituals among indigenous peoples of America and Europe.

Chemistry and Pharmacology

Psilocybin (IUPAC name: [3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate) is a tryptamine compound, structurally related to the amino acid tryptophan and the neurotransmitter serotonin. It is metabolized in the liver by the enzyme monoamine oxidase to produce psilocin, which is the active metabolite that interacts with the serotonin 2A receptor in the brain, leading to its psychoactive effects.

Effects

The effects of psilocybin vary among individuals and are influenced by factors such as dosage, age, weight, personality, emotional state, environment, and history of psychedelic drug use. Common effects include euphoria, peacefulness, spiritual awakening, and visual and auditory distortions. Negative effects can include nausea, vomiting, paranoia, and anxiety. The psychedelic experience, often referred to as a "trip," typically lasts between four to six hours.

Medical Research and Therapeutic Use

Recent years have seen a resurgence in research into the therapeutic potential of psilocybin for treating various mental health disorders, including depression, anxiety, post-traumatic stress disorder (PTSD), and substance use disorders. Clinical trials have shown promising results, with psilocybin therapy being found to produce significant and lasting reductions in depression and anxiety in patients with life-threatening cancer diagnoses, as well as in the treatment of major depressive disorder.

Legal Status

The legal status of psilocybin varies by country. In the United States, psilocybin is classified as a Schedule I controlled substance under the Controlled Substances Act, meaning it is considered to have a high potential for abuse and no accepted medical use. However, recent legislative changes in some states and cities have decriminalized or deprioritized enforcement of laws against the possession and use of psilocybin mushrooms, reflecting growing interest in their medicinal potential and traditional use.

Cultural and Historical Use

The use of psilocybin mushrooms can be traced back to pre-Columbian Mesoamerican societies, as evidenced by ancient stone carvings, murals, and codices. These cultures used the mushrooms in religious and divinatory contexts. In the modern era, psilocybin was first isolated and identified in 1958 by Swiss chemist Albert Hofmann, who also discovered LSD. The popularization of psilocybin in Western culture is often attributed to the publication of "The Doors of Perception" by Aldous Huxley and the research conducted by Timothy Leary and Richard Alpert (later known as Ram Dass) at Harvard University in the early 1960s.

See Also

• Psychedelic therapy
• Entheogen
• Hallucinogen
• Psychedelic drug